Skip to main content

Table 4 Treatment individuals received before spirometry

From: Perseverant, non-indicated treatment of obese patients for obstructive lung disease

  Normal (62) Restriction (35) COPD (36) Asthma (11)
Inhaled Beta 2 -agonists 40.3% (25) 54.3% (19) 69.4% (25) 72.7% (8)
Inhaled corticosteroids 16.1% (10) 28.6% (10) 38.9% (14) 63.6% (7)
Inhaled Anticholinergic 14.5% (9) 14.3% (5) 33.3% (12) 9.1% (1)
Oral corticosteroids 8.1% (5) 14.3% (5) 13.9% (5) 9.1% (1)
Leukotriene antagonists 1.6% (1) 0 5.6% (2) 18.2% (2)